Radiation therapy firm Varian Medical Systems has released its Eclipse 15.5 treatment planning system, which has received U.S. Food and Drug Administration 510(k) clearance.
This version incorporates several new treatment capabilities and also provides treatment planning support for Varian's HyperArc HDRT, a new type of radiosurgery treatment.
Eclipse 15.5 features Varian's multicriteria optimization (MCO) technology, which allows clinicians to explore what happens when different clinical criteria are varied, such as the degree to which particular organs are spared versus coverage of the targeted tumor. MCO uses both RapidPlan and the existing optimization workflows to find the optimal plan for a given patient.
Eclipse 15.5 also offers graphics processing unit (GPU) support, the company said.
